NCT00775255View on ClinicalTrials.gov

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

clarithromycin 250 mg/5 mL powder for oral suspension

Trial Locations (1)

Unknown

Gurgaon

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00775255 - Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions | Biotech Hunter | Biotech Hunter